跳至主要内容
临床试验/NCT01992328
NCT01992328Unknown3 期

IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency

Ajou University School of Medicine0 个研究点目标入组 30 人开始时间: 2013年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
30
主要终点
Infection rate

研究概览

简要总结

Immunoglobulin G deficiency subtypes in patients with asthma six months once a month intravenous immunoglobulin (400mg/kg/4weeks) infection in treatment-related effect on reducing the frequency of asthma exacerbations appreciate.

详细描述

Patients Registration

•It is required to ensure that the patients meet the inclusion criteria for this clinical trial, are free from any items of exclusion criteria, are explained about the participation in the clinical trial along with the informed consent forms.

Procedure

•six months once a month intravenous immunoglobulin (400mg/kg/4weeks)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient from over 16 years to under 75 years
  • Patients diagnosed with asthma over six months ago
  • immunoglobulin G subtypes who were diagnosed with immune deficiency
  • more than 2 years Upper and lower respiratory tract infections
  • , and asthma exacerbations in this regard.
  • ① calculated creatinine clearance ≧ 50ml/min
  • ALT and AST <x 3 times the upper limit of normal
  • ALP <x 3 times the upper limit of normal
  • total bilirubin <x 1.5 times the upper limit of normal

排除标准

  • within six months of the onset of the experiment who received immunoglobulin therapy
  • immune globulin for those with a history of hypersensitivity reactions
  • six months ago, another clinical trial participants.
  • Systemic steroids and immunomodulators, such as asthma control that may affect the resources required drug administration.
  • pregnant or lactating women.

研究组 & 干预措施

Immune Globulin

Experimental

Immunoglobulin G Deficiency Associated with persistent asthma subtypes

干预措施: Immune Globulin (Drug)

结局指标

主要结局

Infection rate

时间窗: 6months

6 months after treatment compared to before treatment 6 months

次要结局

  • adverse events(6months)
  • lung funtion(6 months)
  • Questionnair(6months)
  • steroid(6 months af)
  • IgG subclass(6months)
  • asthma syptoms(6months)
  • Questionnaire(6months)
  • Cytokines(6months)
  • antibiotic(6months)

研究者

发起方
Ajou University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hae-Sim Park

Professor, Department of medicine, Ajou University School of Medicine

Ajou University School of Medicine

相似试验